TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Novavax AB
Closing information (x1000 DKK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
340,736
|
551,005
|
1,049,786 |
| Financial expenses |
33,372
|
456,816
|
516,058 |
| Earnings before taxes |
169,038
|
130,909
|
346,270 |
| EBITDA |
91,615
|
150,301
|
358,837 |
| Total assets |
1,724,307
|
2,428,598
|
2,504,411 |
| Current assets |
89,215
|
138,038
|
1,762,418 |
| Current liabilities |
85,120
|
885,900
|
1,110,047 |
| Equity capital |
1,638,288
|
1,542,699
|
1,394,364 |
| - share capital |
32
|
34
|
33 |
| Employees (average) |
173
|
195
|
167 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
95.0%
|
63.5%
|
55.7% |
| Turnover per employee |
1,970
|
2,826
|
6,286 |
| Profit as a percentage of turnover |
49.6%
|
23.8%
|
33.0% |
| Return on assets (ROA) |
11.7%
|
24.2%
|
34.4% |
| Current ratio |
104.8%
|
15.6%
|
158.8% |
| Return on equity (ROE) |
10.3%
|
8.5%
|
24.8% |
| Change turnover |
-192,044
|
-504,186
|
394,322 |
| Change turnover % |
-36%
|
-48%
|
60% |
| Chg. No. of employees |
-22
|
28
|
167 |
| Chg. No. of employees % |
-11%
|
17% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.